The pharmacological treatment of psychotic depression

Basit Öğe Kaydı
dc.contributor.authorAltinda? A.
dc.contributor.authorÖzkan M.
dc.date.accessioned2024-04-24T17:58:44Z
dc.date.available2024-04-24T17:58:44Z
dc.date.issued2001
dc.departmentDicle Üniversitesien_US
dc.description.abstractPsychotic depression is a severe form of mood disorder characterized by delusions or hallucinations. Patients with psychotic depression have a considerably better response rate to the combination of a tricyclic antidepressant with an antipsychotic or the combination of serotonin selective reuptake inhibitors (SSRIs) with an antipsychotic, amoxapine, or electroconvulsive therapy. The SSRIs alone or atypical antipsychotics alone have yet to receive any widespread recognition, despite some recent studies which indicate that they might be recommended as first-line treatment in psychotic depression. In this paper, the studies about the pharmacological treatment of psychotic depression were reviewed.en_US
dc.identifier.endpage218en_US
dc.identifier.issn1017-7833
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-52549099454en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage212en_US
dc.identifier.urihttps://hdl.handle.net/11468/24077
dc.identifier.volume11en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofKlinik Psikofarmakoloji Bultenien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressantsen_US
dc.subjectAntipsychoticsen_US
dc.subjectPharmacological Treatmenten_US
dc.subjectPsychotic Depressionen_US
dc.titleThe pharmacological treatment of psychotic depressionen_US
dc.title.alternativePsikotik depresyonun farmakolojik tedavisien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu